Rhinomed (ASX:RNO) Ending Cash Position : A$0.19 Mil (As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Rhinomed Ending Cash Position?

Rhinomed's Ending Cash Position for the quarter that ended in Jun. 2023 was A$0.19 Mil.

Rhinomed's quarterly Ending Cash Position increased from Jun. 2022 (A$1.99 Mil) to Dec. 2022 (A$3.63 Mil) but then declined from Dec. 2022 (A$3.63 Mil) to Jun. 2023 (A$0.19 Mil).

Rhinomed's annual Ending Cash Position declined from Jun. 2021 (A$2.34 Mil) to Jun. 2022 (A$1.99 Mil) and declined from Jun. 2022 (A$1.99 Mil) to Jun. 2023 (A$0.19 Mil).

Rhinomed Ending Cash Position Historical Data

The historical data trend for Rhinomed's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rhinomed Ending Cash Position Chart

Rhinomed Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Ending Cash Position

Get a 7-Day Free Trial

1.42

7.76

2.34

1.99

0.19

Rhinomed Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Ending Cash Position	Get a 7-Day Free Trial															2.34	1.60	1.99	3.63	0.19

Rhinomed Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Rhinomed's Ending Cash Position for the fiscal year that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1.984	+	-1.794
	=	0.19

Rhinomed's Ending Cash Position for the quarter that ended in Jun. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3.631	+	-3.441
	=	0.19

Rhinomed Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Rhinomed's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Rhinomed (ASX:RNO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Rhinomed Ltd (ASX:RNO) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

RHNMF:USA

Address

132 Gwynne Street, Level 1, Cremorne, VIC, AUS, 3121

Website

https://www.rhinomed.global

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in the research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies. It operates in one segment which is the identification, acquisition, and commercialization of late-stage consumer therapeutic and medical delivery technologies. The products of the company involve Rhinoswab, Mute, Turbine and Rhinoswab Junior. It operates geographically within North, Central, and South America, Asia-Pacific, Europe, Middle East, and Africa. The company earns majority of its revenue from Asia-Pacific.

Rhinomed (ASX:RNO) Headlines

No Headlines